Characterization of the adduct formed from the reaction between homocysteine thiolactone and low-density lipoprotein: Antioxidant implications

Free Radical Biology and Medicine

Volumn 26, Issue 7-8, 1999, Pages 968-977

  Ferguson, Eric ^a   Hogg, Neil ^a   Antholine, William E ^a   Joseph, Joy ^a   Singh, Ravinder Jit ^a   Parthasarathy, Sampath ^b   Kalyanaraman, B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Electron spin resonance; Homocystamide adduct; Homocysteine; Homocysteine thiolactone; Lipid peroxidation; Low density lipoprotein; Protein thiols

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; AMINE; ANTIOXIDANT; COPPER; HOMOCYSTEINE THIOLACTONE; LIPID; LOW DENSITY LIPOPROTEIN; MYOGLOBIN; N ETHYLMALEIMIDE; NITROXIDE; SULFONIC ACID DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOESTER; THIOL;

ARTICLE; ATHEROSCLEROSIS; CHEMICAL REACTION; ELECTRON SPIN RESONANCE; LIPID PEROXIDATION; PRIORITY JOURNAL;

ANTIOXIDANTS; ELECTRON SPIN RESONANCE SPECTROSCOPY; HOMOCYSTEINE; HUMANS; KINETICS; LIPOPROTEINS, LDL; MESYLATES; OXIDATION-REDUCTION; PROTEIN BINDING; RADIATION-PROTECTIVE AGENTS; SPIN LABELS; THIOSULFATE SULFURTRANSFERASE;

EID: 0032953962     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00287-1     Document Type: Article

References (43)

1. McCully K.S. Homocysteine and vascular disease. Nature Med. 2:1996;386-389.
2. McCully K.S. Chemical pathology of homocysteine I. Atherogenesis. Ann. Clin. Lab. Med. 23:1993;477-493.
3. Ueland P., Refsum H. Plasma homocysteine, a risk factor for vascular disease plasma levels in health, disease, and drug therapy . J. Lab. Clin. Med. 51:1989;159-170.
4. Yla-Herttuala S., Palinski W., Rosenfeld M., Parthasarathy S., Carew T., Butler S., Witztum J., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions in rabbits and man. J. Clin. Invest. 84:1989;1086-1095.
5. Steinberg D., Parthasarathy S., Carew T., Khoo J., Witztum J. Beyond cholesterol oxidative modifications of low density lipoprotein that increase its atherogenicity . N. Engl. J. Med. 320:1989;915-924.
6. Parthasarathy S. Modified lipoproteins in the pathogenesis of atherosclerosis. 1994;Landes Press, Austin.
7. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 98:1996;5-7.
8. Starkebaum G. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1986;1370-1376.
9. Wall R.T., Harlan J.M., Harker L.A., Striker G.E. Homocysteine-induced endothelial cell injury in vitro a model for the study of vascular injury . Thromb. Res. 18:1980;113-121.
10. Heinecke J.W., Rosen H., Suzuki L.A., Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262:1987;10098-10103.
11. Heinecke J.W., Kawamura M., Suzuki L., Chait A. Oxidation of low density lipoprotein by thiols superoxide-dependent and -independent mechanisms . J. Lipid Res. 34:1993;2051-2061.
12. Sparrow C.W., Olzewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid Res. 34:1993;1219-1228.
13. Parthasarathy S. Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim. Biophys. Acta. 917:1987;337-340.
14. Santanam N., Parthasarathy S. Cellular cysteine does not contribute to the initiation of LDL oxidation. J. Lipid Res. 36:1995;2203-2211.
15. Halvorsen B., Brude I., Drevon C.A., Nysom J., Ose L., Christiansen E.N., Nenseter M.S. Effect of homocysteine on copper-ion catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modifications of low density lipoprotein. J. Lipid Res. 37:1996;1591-1600.
16. Lynch S.M., Frei B. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochim. Biophys. Acta. 1345:1997;215-221.
17. Ferguson E., Singh R.J., Hogg N., Kalyanaraman B. The mechanism of apolipoprotein B-100 thiol depletion during oxidative modification of LDL. Arch. Biochem. Biophys. 341:1997;287-294.
18. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures. J. Biol. Chem. 272:1997;1935-1942.
19. Benesch R., Benesch R.E. Formation of peptide bonds by aminolysis of homocysteine thiolactone. J. Amer. Chem. Soc. 78:1956;1597-1599.
20. Naruszewicz M., Mirkiewicz E., Olszewski A.J., McCully K.S. Thiolation of low-density lipoprotein by homocysteine thiolactone causes increased aggregation and interaction with cultured macrophages. Nutrit. Metab. Cardiovasc. Dis. 4:1994;70-77.
21. Olszewski A.J., McCully K.S. Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic. Biol. Med. 14:1993;683-693.
22. Ferguson E., Parthasarathy S., Joseph J., Kalyanaraman B. Generation and initial characterization of a novel polyclonal antibody directed against homocysteine thiolactone-modified low density lipoprotein. J. Lipid Res. 39:1998;925-933.
23. Berliner L.J., Grunwald J., Hankovsky H.O., Hideg K. A novel reversible thiol-specific spin label papain active site labeling and inhibition . Anal. Biochem. 119:1982;450-455.
24. Hatch F.T., Lees R.S. Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6:1968;2-68.
25. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
26. Riddles P.W., Blakely R.L., Zerner B. Ellman's reagent 5,5,dithiobis (2-nitrobenzoic acid)-a reexamination . Anal. Biochem. 9:1979;75-81.
27. Hogg N., Darley-Usmar V.M., Wilson M.T., Moncada S. The oxidation of a-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide. FEBS Lett. 326:1993;199-203.
28. Steinbrecher U.P., Witztum J.L., Parthasarathy S., Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 7:1987;135-143.
29. Swain J.A., Darley-Usmar V.M., Gutteridge J.M.C. Peroxynitrite releases copper from caeruloplasmin implications for atherosclerosis . FEBS Lett. 342:1994;49-52.
30. Lim Y.S., Cha M.K., Kim H.K., Uhm T.B., Park J.W., Kim K., Kim I.H. Removals of hydrogen peroxide and hydroxyl radical by thiol-specific antioxidant protein as a possible role in vivo. Biochem. Biophys. Res. Commun. 192:1993;273-280.
31. Hogg N., Joseph J., Kalyanaraman B. The oxidation of α-tocopherol by trolox and peroxynitrite. Arch. Biochem. Biophys. 314:1995;153-158.
32. Hogg N., Rice-Evans C., Wilson M.T., Paganga G., Borne C. The role of lipid hydroperoxides in the myoglobin-dependent oxidation of LDL. Arch. Biochem. Biophys. 314:1994;39-44.
33. Girotti A.W. Mechanisms of lipid peroxidation. J. Free Rad. Biol. Med. 1:1985;87-95.
34. Thomas C.E., Ohlweiler D.F., Kalyanaraman B. Multiple mechanisms for inhibition of low density lipoprotein oxidation by novel cyclic nitrone spin traps. J. Biol. Chem. 269:1994;28055-28061.
35. Jewett S.L., Coshing S., Gillespie F., Smith D., Sparks S. Reaction of bovine-liver copper-zinc superoxide dismutase with hydrogen peroxide. Eur. J. Biochem. 180:1989;569-575.
36. Esterbauer H., Gebicki H., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
37. Singh R.J., Feix J.B., Mchaourab H.S., Hogg N., Kalyanaraman B. Spin-labeling study of oxidative damage to low-density lipoprotein. Arch. Biochem. Biophys. 320:1995;155-161.
38. Peisach J., Blumberg W.E. Structural implications derived from the analysis of electron paramagnetic resonance spectra of natural and artificial copper proteins. Arch. Biochem. Biophys. 165:1974;691-708.
39. 2C leukemic lymphocytes. Biochimie. 68:1986;723-730.
40. 2+-stimulated oxidation of low-density lipoprotein. Arch. Biochem. Biophys. 315:1994;244-254.
41. Hajjar K.A., Nachman R.L. The role of lipoprotein(a) in atherogenesis and thrombosis. Annu. Rev. Med. 47:1996;423-442.
42. Superko H.R. New aspects of risk factors for the development of atherosclerosis including small low-density lipoprotein, homocyst(e)ine, and lipoprotein(a). Curr. Opin. Cardiol. 10:1995;347-354.
43. Koschisky M.L., Marcovina S.M. Lipoprotein(a) structural implications for pathophysiology . Int. J. Clin. Lab. Res. 27:1997;14-23.